KRAS and cancer: High levels of nuclear β-catenin and activated KRAS are considered the major drivers of cancer stem cell (CSC) expansion and cancer dissemination, the leading cause of chemoradiation therapy (CRT) resistance in various aggressive and recurrent tumors like that of the colon and brain (4–23).